Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable adenosylhomocysteinase SahH (S-adenosyl-L-homocysteine hydrolase) (adohcyase) | 0.0504 | 1 | 1 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0312 | 0.5358 | 0.5358 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0312 | 0.5358 | 0.5358 |
Plasmodium vivax | adenosylhomocysteinase(S-adenosyl-L-homocystein e hydrolase), putative | 0.0504 | 1 | 1 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.0504 | 1 | 0.5 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0312 | 0.5358 | 0.5358 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0504 | 1 | 1 |
Entamoeba histolytica | adenosylhomocysteinase, putative | 0.0504 | 1 | 1 |
Toxoplasma gondii | adenosylhomocysteinase, putative | 0.0504 | 1 | 1 |
Echinococcus multilocularis | adenosylhomocysteinase | 0.0504 | 1 | 1 |
Leishmania major | S-adenosylhomocysteine hydrolase | 0.0504 | 1 | 1 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.0158 | 0.1644 | 0.1644 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.0504 | 1 | 1 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.009 | 0 | 0.5 |
Trypanosoma brucei | S-adenosylhomocysteine hydrolase, putative | 0.0504 | 1 | 0.5 |
Trypanosoma cruzi | S-adenosylhomocysteine hydrolase, putative | 0.0504 | 1 | 0.5 |
Treponema pallidum | adenosine deaminase | 0.009 | 0 | 0.5 |
Mycobacterium leprae | putative S-adenosyl-L-homocysteine hydrolase SahH | 0.0504 | 1 | 1 |
Plasmodium falciparum | adenosylhomocysteinase | 0.0504 | 1 | 1 |
Mycobacterium ulcerans | S-adenosyl-L-homocysteine hydrolase | 0.0504 | 1 | 1 |
Trichomonas vaginalis | adenosylhomocysteinase, putative | 0.0504 | 1 | 1 |
Loa Loa (eye worm) | adenosylhomocysteinase | 0.0504 | 1 | 1 |
Schistosoma mansoni | adenosylhomocysteinase | 0.0312 | 0.5358 | 0.5358 |
Toxoplasma gondii | S-Adenosyl homocysteine hydrolase | 0.0504 | 1 | 1 |
Echinococcus granulosus | adenosylhomocysteinase | 0.0504 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.